Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Laurie Keating currently holds 33,350 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laurie Keating has been a net seller of ALNY stock. They have purchased $941.5K and sold $31.4M worth of shares.
Laurie Keating's most recent insider trade was on Jun 11, 2026, when they sold 33,350 shares at $0.00 per share.
Laurie Keating serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 91 insider transactions totaling $32.3M over their tenure at the company.
Laurie Keating holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Laurie Keating has shown a selling trading pattern, with $941.5K in total purchases and $31.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Laurie Keating was on Jul 13, 2020, when they sold $2.5M worth of ALNY shares. This transaction involved 15,618 shares at $161.32 per share.
Laurie Keating currently owns 33,350 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Laurie Keating's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Laurie Keating has 91 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..
Set alerts for Laurie Keating and 40,000+ other insiders.